Sort   by:  
 Page size 
ProteomicsSame same but different – The global response of Escherichia coli to five different LpxC inhibitors
A promising but yet clinically unexploited antibiotic target in difficult-to-treat Gram-negative bacteria is LpxC, the key enzyme in the biosynthesis of lipopolysaccharides (LPS), which are the major constituents of the outer membrane. To gain insights into the mode of action of five different LpxC ...
ORGANISM(S): Escherichia coli 
2024-06-16 | PXD043195 | Pride
Lipopolysaccharide Lps Antibiotics Phospholipid Outer membrane Ftsh 
ProteomicsComparison of Proteomic Responses
To facilitate antibiotic research, we have developed a compendium of proteomic responses that allows rapid classification of compounds into those with precedented and unprecedented modes of action. We gathered more than 100 proteomic response profiles of B. subtilis to treatment with antibiotics. To...
ORGANISM(S): Bacillus subtilis subsp. subtilis str. 168 
2020-10-01 | PXD011640 | Pride
Bacillus subtilis Marker proteins Antibiotics 
UnknownMenke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles.
Not available
S-EPMC11040166 | biostudies-literature
Sort   by:  
 Page size